WHO ICTRP trial
A pilot, randomized, open-label, non-active comparator controlled clinical trial…
ISRCTN64393078 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN64393078 |
|---|---|
| Public title | A pilot, randomized, open-label, non-active comparator controlled clinical trial to evaluate the effects of letermovir prophylaxis on T-cell immune activation in participants with treated HIV-1 Infection |
| Scientific title | A pilot, randomized, open-label, non-active comparator controlled clinical trial to evaluate the effects of letermovir prophylaxis on T-cell immune activation in participants with treated HIV-1 Infection |
| Primary sponsor | University College London |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | United Kingdom |
| Conditions | Human immunodeficiency virus 1 Infections and Infestations HIV |
| Interventions | This is a randomized, parallel, and controlled, open-label clinical trial. A 1:1 randomisation procedure will assign the participant to receive either letermovir 480mg PO OD (letermovir oral formulation of 240mg), or no additional… |
| Registration date | Dec 15, 2023 |
| Target size | 36 |
| Secondary IDs | 2020-000288-22;Nil known;125096, IRAS 1006176, CPMS 60394 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: